ArticleOncotarget2019

Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent.

Anne-Julie Cloux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.